Status:
COMPLETED
Antibody Detection of Vaccine-Induced Secretory Effects
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Covid19
Humoral Acquired Immunodeficiency
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this research study is to conduct a prospective longitudinal surveillance research study, enrolling approximately 60 lactating mothers who receive the SARS-CoV-2 vaccine, and then follo...
Detailed Description
As the global and pandemic spread of the novel coronavirus (SARS-CoV-2, COVID-19) continues, many knowledge gaps remain regarding the epidemiology and transmission of infection, the immunological resp...
Eligibility Criteria
Inclusion
- Age ≥ 18.0 years at the time of enrollment
- Currently lactating mothers
- Planning to receive the SARS-CoV-2 vaccine in the next 60 days, or vaccinated with the SARS-CoV-2 vaccine within the past 60 days
- Cell phone that can be used for text messaging or web-based viewing of surveys
- Willing and able to provide informed consent
- Ability to comply with all study related evaluations and follow-up
Exclusion
- Any condition or illness that makes study participation ill-advised
Key Trial Info
Start Date :
February 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04895475
Start Date
February 19 2021
End Date
August 31 2023
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229